WILMINGTON, Mass. (Apr. 2, 2018) – CutisPharma announced today the commercial launch […]
WILMINGTON, Mass. (Mar. 26, 2018) – CutisPharma, Inc. (“CutisPharma”), a specialty pharmaceutical […]
WILMINGTON, Mass. (Jan. 29, 2018) – CutisPharma announced today that the US Food and Drug Administration (FDA)
Unrestricted Grant from Company to Support Awareness and Advocacy Efforts WILMINGTON, Mass. […]
Robert M. Palladino named as Chief Financial Officer, Dr. Yatindra Joshi as […]
©2016 CutisPharma, Inc.
FI℞ST® and the FI℞ST® logo are registered
trademarks of CutisPharma, Inc.